Flow cytometric analysis of Pig-a gene mutation and chromosomal damage induced by procarbazine hydrochloride in CD-1 mice

Environmental and Molecular Mutagenesis

Volumn 54, Issue 4, 2013, Pages 294-298

  Phonethepswath, Souk ^a   Avlasevich, Svetlana L ^a   Torous, Dorothea K ^a   Mereness, Jared ^a   Bemis, Jeffrey C ^a   Macgregor, James T ^b   Dertinger, Stephen D ^a  

^a LITRON LABORATORIES   (United States)

^b Toxicology Consulting Services   (United States)

Author keywords

Flow cytometry; Micronuclei; Mutation; Pig a; Procarbazine

Indexed keywords

PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL GLYCAN A; PROCARBAZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME DAMAGE; CONTROLLED STUDY; DRUG MEGADOSE; ERYTHROCYTE; FLOW CYTOMETRY; GENE MUTATION; GENOTOXICITY; HEMATOPOIETIC CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; RETICULOCYTE;

ANIMALS; ANTIGENS, CD24; ANTINEOPLASTIC AGENTS; CHROMOSOMES; DNA DAMAGE; FLOW CYTOMETRY; MALE; MEMBRANE PROTEINS; MICE; MICRONUCLEUS TESTS; MUTAGENS; PROCARBAZINE; RETICULOCYTES;

ANIMALIA; MUS; SUIDAE;

EID: 84875919538     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21758     Document Type: Article

References (24)

1. Armand J-P, Ribrag V, Harrousseau J-L, Abrey L. 2007. Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors. Ther Clin Risk Manage 3:213-224.
2. Bronzetti G, Zeiger E, Malling HV. 1979. Genetic toxicology of procarbazine in bacteria and yeast. Mutat Res 68:51-58.
3. Clive D, Turner N, Krehl R. 1988. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk+/-) locus of mouse lymphoma cells. Mutagenesis 3:83-87.
4. Collins FS, Gray GM, Bucher JR. 2008. Transforming environmental health protection. Science 319:906-907.
5. Dertinger SD, Bryce SM, Phonethepswath S, Avlasevich SL 2011. When pigs fly: Immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis. Mutat Res 721:163-170.
6. Dertinger SD, Camphausen K, MacGregor JT, Bishop ME, Torous DT, Avlasevich S, Cairns S, Tometsko CR, Menard C, Muanza T, Chen Y, Miller RK, Cederbrant K, Sandelin K, Pontén I, Bolcsfoldi G. 2004. Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood. Environ Mol Mutagen 44:427-435.
7. Dertinger SD, Phonethepswath S, Avlasevich SL, Torous DK, Mereness J, Bryce SM, Bemis JC, Bell S, Weller P, MacGregor JT. 2012. Efficient monitoring of in vivo Pig-a gene mutation and chromosomal damage: Summary of 7 published studies and results from 11 new reference compounds. Toxicol Sci 130:328-348.
8. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ. 2007. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95:5-12.
9. Dobrovolsky VN, Miura D, Heflich RH, Dertinger SD 2010. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ Mol Mutagen 51:825-835.
10. IARC. 1981. Some antineoplastic and immunosuppressive agents. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. International Agency for Research on Cancer, Lyon, France. 26:311-339.
11. Kaldor JM, Day NE, Hemminki K. 1988. Quantifying the carcinogenicity of antineoplastic drugs. Eur J Cancer Clin Oncol 24:703-711.
12. Kavlock RJ, Austin CP, Tice RR. 2009. Toxicity testing in the 21st century: Implications for human health risk assessment. Risk Anal 29:485-487.
13. Kimoto T, Suzuki K, Kobayashi X, Dobrovolsky VN, Heflich RH, Miura D, Kasahara Y. 2011. Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: Direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchor protein expression. Mutat Res 723:36-42.
14. Levine EG, Bloomfield CD. 1992. Leukemias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure. Semin Oncol 19:47-84.
15. McCann J, Choi E, Yamasaki E, Ames BN. 1975. Detection of carcinogens and mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci USA 72:5135-5139.
16. Phonethepswath S, Franklin D, Torous DK, Bryce SM, Bemis JC, Raja S, Avlasevich S, Weller P, Hyrien O, Palis J, MacGregor JT, Dertinger SD. 2010. Pig-a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114:59-70.
17. 6-methylguanine. Carcinogenesis 18:2191-2197.
18. Prough RA, Tweedie DJ. 1987. Procarbazine. In: Powis G, Prough RA, editors. Metabolism and Action of Anti-Cancer Drugs. London: Taylor and Francis. 29-47.
19. Souliotis VL, Valavanis C, Boussiotis VA, Pangalis GA, Kyrtopoulos SA. 1994. Comparitive dosimetry of O6-methylguanine in human and rodents treated with procarbazine. Carcinogenesis 15:1675-1680.
20. Suter W. 1987. Mutagenicity of procarbazine for V79 Chinese hamster fibroblasts in the presence of various metabolic activation systems. Mutagenesis 2:27-32.
21. ™Mouse: Strong clastogenicity and organ-specific induction of lacZ mutations. Mutat Res 444:269-281.
22. Tometsko AM, Torous DK, Dertinger SD. 1993. Analysis of micronucleated cells by flow cytometry. 1. Achieving high resolution with a malaria model. Mutat Res 292:129-135.
23. Torous DK, Hall NE, Illi-Love AH, Diehl MS, Cederbrant K, Sandelin K, Pontén I, Bolcsfoldi G, Ferguson LR, Pearson A, Majeska JB, Tarca JP, Hynes GM, Lynch AM, McNamee JP, Bellier PV, Parenteau M, Blakey D, Bayley J, van der Leede BJ, Vanparys P, Harbach PR, Zhao S, Filipunas AL, Johnson CW, Tometsko CR, Dertinger SD. 2005. Interlaboratory validation of a CD71-based flow cytometric method (MicroFlow) for the scoring of micronucleuated reticulocytes in mouse peripheral blood. Environ Mol Mutagen 45:44-55.
24. Vian L, Bichet N, Gouy D. 1993. The in vitro micronucleus test on isolated human lymphocytes. Mutat Res 291:93-102.